Q&A: Matthias Mann on Mass Spectrometry, Human Proteome Project, and His Own Research

In the second of a two-part interview, Mann, center director of the Max Planck Institute’s department of proteomics and signal transduction, shares his thoughts about the development of mass spectrometry as the dominant technology in proteomics, the proposal to map the human proteome, and his own work.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.